Literature DB >> 3888432

The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion.

J J Offerman, D T Sleijfer, N H Mulder, S Meijer, H Schraffordt Koops, A J Donker.   

Abstract

On the assumption that hemodynamic changes in renal blood flow are the initial expression of cis-diamminedichloroplatinum (CDDP)-related nephrotoxicity, we treated patients with metastatic non-seminomatous testicular carcinoma during CDDP infusion with captopril. This angiotensin-converting enzyme inhibitor significantly attenuated the initial decrease in effective renal plasma flow and can probably be used to protect the kidneys against CDDP-induced nephrotoxicity.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3888432     DOI： 10.1007/bf00258130

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


  16 in total

1.  INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors:  B ROSENBERG; L VANCAMP; T KRIGAS
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

2.  A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow.

Authors:  A J Donker; G K van der Hem; W J Sluiter; H Beekhuis
Journal:  Neth J Med       Date:  1977       Impact factor: 1.422

Review 3.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

Review 4.  Role of the intrarenal renin-angiotensin system in the control of renal function.

Authors:  N R Levens; M J Peach; R M Carey
Journal:  Circ Res       Date:  1981-02       Impact factor: 17.367

5.  Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma.

Authors:  S Meijer; D T Sleijfer; N H Mulder; W J Sluiter; J Marrink; H S Koops; T M Brouwers; J Oldhoff; G K van der Hem; E Mandema
Journal:  Cancer       Date:  1983-06-01       Impact factor: 6.860

6.  Mechanism of increased renal prostaglandin E2 in uranyl nitrate-induced acute renal failure.

Authors:  A Chaudhari; M A Kirschenbaum
Journal:  Prostaglandins       Date:  1983-11

7.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.

Authors:  L H Einhorn; J Donohue
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

8.  Stimulation of PGE2 synthesis by mercuric chloride in rat glomeruli and glomerular cells in vitro.

Authors:  J D Sraer; L Baud; J Sraer; F Delarue; R Ardaillou
Journal:  Kidney Int Suppl       Date:  1982-05       Impact factor: 10.545

9.  Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.

Authors:  E Cvitkovic; J Spaulding; V Bethune; J Martin; W F Whitmore
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

10.  High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

Authors:  D M Hayes; E Cvitkovic; R B Golbey; E Scheiner; L Helson; I H Krakoff
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860
View more
  4 in total

Review 1.  Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review.

Authors:  V Pinzani; F Bressolle; I J Haug; M Galtier; J P Blayac; P Balmès
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 3.  Cisplatin: a review of clinical applications and renal toxicity.

Authors:  D T Sleijfer; S Meijer; N H Mulder
Journal:  Pharm Weekbl Sci       Date:  1985-12-13

4.  Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin.

Authors:  O F dos Santos; M A Boim; E J Barros; E Pirotzky; P Braquet; N Schor
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.